4/14/2017 small bios pick

It has been for a long while I have not played small bios since I changed my strategy in 2017 (mostly big cap stocks and ETFs, etc). It is time to review several possible play in small bio-techs. I treat all these small bio-techs play as speculation play.

The first one is PGNX: a prostate cancer player.

• the price bounced off the level support around $8
• weekly chart seems stop bleeding
• both weekly fast and slow STOs get to oversold zone

http://schrts.co/5kbJJ7

In summary, the buy levels are $8 and $7. The initial buy batch entry is around $8 and second batch entry is around $7. The upside target is around 11+ and above.

The second one is NLNK: an inhibitor method to attack immune system disease company.

• we played this stock in last September from $12 to around $15 (blue box break out)
• the bigger green box break out is missed (not followed the stock since sold)
• now price come into the top of break out green box.
• daily both slow and fast STOs indicate oversold.
•  the support levels at the top of box is around $15, and $14.

http://schrts.co/Py176O

In summary, the buy entry is $14~$15, if the price not back down to $14~$15, the buyer can chase. The upside target is around is gap fill at $23 at least.

The third one is ZIOP: a synthetic immuno-oncology company.  

• both monthly and daily price break out
• both daily and monthly short term MAs act as supports, very strong support
• all technical indicators run positively

http://schrts.co/l7nmgV

http://schrts.co/yw29G8

In summary, buy breakout above $8 or support at $7, actually just buy it at current level, this guy will run much higher. The upside target is around $11

Note: my personal opinion is not for investment purpose, but for education and illustration